HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Spratt, K. A. Search for Related Content PubMed PubMed Citation Articles by Spratt, K. A.

Dr Spratt is clinical associate professor of medicine at the University of Pennsylvania School of Medicine in Philadelphia.

Correspondence to Kelly Anne Spratt, DO, FACC, Penn Presbyterian Medical Center, 51 N 39th St, Philadelphia Heart Institute, Suite 2C, Philadelphia, PA 19104-2640. E-mail: kelly.spratt{at}uphs.upenn.edu

The United States is experiencing a marked increase in rates of diabetes mellitus and metabolic syndrome, almost certainly in part due to the increase in obesity rates. This phenomenon is likely to also result in an increased risk of coronary artery disease as risk factors increase exponentially. This article defines diabetic dyslipidemia, the rationale for aggressive treatment, and options for ongoing management, including nonpharmacologic therapy and medications, alone or in combination, for management of all aspects of the lipid profile.